Medication info

Aminosin Plus Injection

Prescription medicationInjections
Ingredient · strength
L-Leucine›620mg / 100mLL-Isoleucine›510mg / 100mLL-Lysine Hydrochloride›493mg / 100mLL-Valine›493mg / 100mLL-Phenylalanine›476mg / 100mLL-Histidine›408mg / 100mLL-Threonine›357mg / 100mLL-Methionine›340mg / 100mLL-Tryptophan›153mg / 100mLL-Alanine›1760mg / 100mLL-Arginine›978mg / 100mLGlycine›876mg / 100mLL-Proline›578mg / 100mLL-Serine›425mg / 100mLL-Tyrosine›34mg / 100mL
Manufacturer / importer
Korea Pharmaceutical Industries Co., Ltd.
Appearance
A colorless or pale yellow transparent liquid in a colorless transparent glass vial.
Packaging
200 milliliters/vial, 250 milliliters/vial
Approval status
Active

MFDS item code 202200749 · Approved 2022.02.17

Summary

Main use
Amino acid supplementation in patients for whom oral or gastrointestinal nutritional support is difficult
Who uses it
Adults · Children
Adult dosage
The intravenous dose depends on the patient's clinical condition and requirements for amino acids, electrolytes, and fluids (nutritional status and/or the degree of nitrogen catabolism due to disease). ○ Daily dose: For adults, the reference dose is 0.8g of amino acids per kg of body weight per day (equivalent to 9.5mL of this drug). Administer at least 180kcal of nonprotein energy source per 1g of nitrogen. Adjust the dose and infusion rate as appropriate according to the patient's age, weight, and clinical condition. Administer by intravenous infusion into a central vein. This drug should be administered with glucose or another source sufficient to provide adequate calories for parenteral nutrition.
Children's dosage
For infants, the reference daily dose is 2.2g of amino acids per kg of body weight (equivalent to 26mL of this drug).

Ingredients

Manufacturer
Korea Pharmaceutical Industries Co., Ltd.

Efficacy & effects

Amino acid supplementation in patients for whom oral or gastrointestinal nutritional support is difficult

View approved original text

This medication is used to supplement necessary amino acids for patients who are unable to receive nutrition orally or through the gastrointestinal tract, or when such supply is insufficient. It helps improve the patient's nutritional status and aids recovery.

Dosage and Administration

Adult dosage

The intravenous dose depends on the patient's clinical condition and requirements for amino acids, electrolytes, and fluids (nutritional status and/or the degree of nitrogen catabolism due to disease). ○ Daily dose: For adults, the reference dose is 0.8g of amino acids per kg of body weight per day (equivalent to 9.5mL of this drug). Administer at least 180kcal of nonprotein energy source per 1g of nitrogen. Adjust the dose and infusion rate as appropriate according to the patient's age, weight, and clinical condition. Administer by intravenous infusion into a central vein. This drug should be administered with glucose or another source sufficient to provide adequate calories for parenteral nutrition.

Children's dosage

For infants, the reference daily dose is 2.2g of amino acids per kg of body weight (equivalent to 26mL of this drug).

Precautions

This medication must be used strictly according to a physician's instructions and should not be used arbitrarily without a prescription. It should not be administered to patients with allergic reactions to its components, those with severely impaired liver function, or patients with severe kidney disease. Use should also be avoided in patients with congenital amino acid metabolism disorders or those with heart failure, pulmonary edema, or oliguria. Particular caution is needed for specific patient groups, such as those with severe dehydration or electrolyte imbalances, and for those with impaired liver or kidney function. Dosage should be adjusted based on the patient's condition. During the administration of this medication, severe side effects such as allergic reactions or anaphylaxis may occur, so careful monitoring is necessary. During non-oral nutrition therapy, blood ammonia levels may rise, necessitating regular blood tests to monitor the condition. If any abnormal symptoms occur, administration should be stopped immediately. Additionally, electrolyte concentrations, blood glucose, fluid balance, and liver and kidney function should be regularly assessed to ensure they remain normal. This medication should be administered alongside appropriate energy sources, and particularly when combined with glucose, blood sugar and urine glucose levels should be carefully monitored. In the case of overdose, issues such as increased blood volume, electrolyte imbalance, and acidosis may arise, so the infusion rate should be adjusted and stopped immediately if abnormal symptoms occur. The safety of this medication has not been fully established for pregnant or breastfeeding women, and it should only be used when the therapeutic benefits outweigh the risks. In the case of children and the elderly, special caution is needed as physiological functions may differ; particularly in infants under 2 years old, administration should be done carefully while maintaining a shaded condition. This medication is for single use only; it should be used immediately after opening and any remaining contents should be discarded. When storing, avoid direct sunlight and keep at room temperature. Do not use if the contents are discolored or cloudy, or if the packaging is damaged. Finally, maintain strict aseptic conditions while preparing and administering this medication to reduce the risk of infection.

Side effects

  • Anaphylaxis
  • anaphylactic reaction
  • hypersensitivity reaction
  • fever
  • chills
  • hypotension
  • hypertension
  • arthralgia
  • myalgia
  • urticaria
Show 23 more
  • rash
  • pruritus
  • erythema
  • headache
  • pulmonary vascular deposition
  • azotemia
  • hyperammonemia
  • liver failure
  • cirrhosis
  • liver fibrosis
  • cholestasis
  • hepatic steatosis
  • increased blood bilirubin
  • increased liver enzymes
  • cholecystitis
  • cholelithiasis
  • thrombophlebitis
  • phlebitis
  • pain
  • erythema
  • warmth
  • swelling
  • sclerosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. A cool place between 1 and 25 degrees Celsius is suitable for storage. Take care not to place it in excessively hot or cold areas.

Appearance and packaging

Appearance

A colorless or pale yellow transparent liquid in a colorless transparent glass vial.

Package unit

200 milliliters/vial, 250 milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.